Status | Study |
Completed |
Study Name: Growth Hormone (GH) in Congenital Adrenal Hyperplasia Condition: Adrenal Hyperplasia, Congenital Date: 2017-05-16 |
Recruiting |
Study Name: Cushing's Osteoporosis Specificities Condition: Osteoporosis in Cushing's Syndrome Osteoporosis in Post-menopausal Women Date: 2017-05-12 Interventions: Other: Osteodensitometry and pQCT The peripheral Quantitative Computed analyses the bone architecture wi |
Recruiting |
Study Name: Adult Height Prediction in Congenital Adrenal Hyperplasia Condition: Congenital Adrenal Hyperplasia Date: 2017-05-11 Interventions: Other: Collection of growth and bone maturation data |
Recruiting |
Study Name: Primary Aldosteronism In Hypertensive Patients in China Condition: Hyperaldosteronism; Primary Hypertension Secondary Date: 2017-04-28 Interventions: Diagnostic Test: Aldosterone/renin ratio (ARR) testing |
Active, not recruiting |
Study Name: Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma Condition: Cushing Syndrome Adrenocortical Carcinoma Date: 2017-04-26 Interventions: Drug: Abiraterone Acetate Cohort 1: |
Not yet recruiting |
Study Name: The Occurence of Secondary Adrenal Insufficiency in Hospitalised Patients With Exacerbation of COPD in Glucocorticoid Treatment Related to Differenct Gene Polymorphisms of the Glucocorticoid Receptor Gene Condition: Adrenal Insufficiency Date: 2017-04-17 |
Not yet recruiting |
Study Name: Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Peritoneal Carcinomatosis Date: 2017-04-02 Interventions: Drug: Cisplatin |
Recruiting |
Study Name: Screening for Primary Aldosteronism in a Population of Patients With Hypertension Condition: Primary Aldosteronism Hypertension Hypertension Secondary Date: 2017-03-27 |
Not yet recruiting |
Study Name: Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition Condition: Iatrogenic Cushing's Disease Date: 2017-03-17 Interventions: Drug: AZD4017 and prednisolone |
Not yet recruiting |
Study Name: Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients Condition: Adrenal Insufficiency Adrenal Cancer Date: 2017-03-14 Interventions: Diagnostic Test: Cosyntropin stimulation test At 0800h to 0900h, a 25 mm plastic intravenous line will b |